Huntington's disease (HD) is caused by an expanded glutamine tract, which confers a novel
INTRODUCTION
Huntington's disease (HD) is a late-onset movement disorder in which graded loss of striatal neurons is triggered by expansion of an amino terminal polyglutamine segment in huntingtin to Ͼ38 residues (Huntington's Disease Collaborative Research Group, 1993) . Intriguingly, the glutamine tract length is inversely correlated with onset, though most cases begin in midlife due to mutant huntingtin with ϳ42-52 glutamines. By contrast, shorter expanded arrays (ϳ38-41 residues) may be nonpenetrant or cause late onset HD (Rubinsztein et al., 1996; McNeil et al., 1997) , while longer tracts (ϳ55 to Ͼ100 residues) provoke onset in childhood (Gusella & MacDonald, 1995) .
HD pathogenesis appears to entail a dominant property of the mutant protein, possibly an altered conformation due to the expanded glutamine tract. Aggregated forms of huntingtin's amino terminus, including nuclear inclusions and neuropil deposits (DiFiglia et al., 1997; Becher et al., 1998) , are found in HD brain, suggesting that the property that propels their formation is intimately involved in the disease process. However, it remains uncertain whether the initial trigger for pathogenesis due to this novel prop-
